Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study

by on 20 de desembre de 2021 with No hi ha comentaris
  • Bordonaro, R., Calvo, A., Auriemma, A., Hollebecque, A., Rubovszky, G., Saunders, M. P., . . . Tabernero, J. (2021). Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study. Esmo Open, 6(5). https://doi.org/10.1016/j.esmoop.2021.100270

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *